| Literature DB >> 26270206 |
Rodolfo Sacco1, Michela Antonucci2, Irene Bargellini3, Sara Marceglia4, Valeria Mismas1, Giuseppe Cabibbo5.
Abstract
Entities:
Keywords: HCC; TACE; combination therapy; intermediate stage; sorafenib
Mesh:
Substances:
Year: 2015 PMID: 26270206 DOI: 10.2217/FON.15.173
Source DB: PubMed Journal: Future Oncol ISSN: 1479-6694 Impact factor: 3.404